-
1
-
-
0034128751
-
Genetic, biochemical, and clinical features of chronic granulomatous disease
-
Segal BH, Leto TL, Gallin JI, Malech HL, Holland SM. Genetic, biochemical, and clinical features of chronic granulomatous disease. Medicine (Baltimore) 2000; 79:170-200.
-
(2000)
Medicine (Baltimore)
, vol.79
, pp. 170-200
-
-
Segal, B.H.1
Leto, T.L.2
Gallin, J.I.3
Malech, H.L.4
Holland, S.M.5
-
2
-
-
0034040532
-
Chronic granulomatous disease. Report on a national registry of 368 patients
-
Winkelstein JA, Marino MC, Johnston RB Jr, Boyle J, Curmutte JT, Gallin JI, et al. Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine (Baltimore) 2000; 79:155-169.
-
(2000)
Medicine (Baltimore)
, vol.79
, pp. 155-169
-
-
Winkelstein, J.A.1
Marino, M.C.2
Johnston Jr, R.B.3
Boyle, J.4
Curmutte, J.T.5
Gallin, J.I.6
-
3
-
-
3442877820
-
Gastrointestinal involvement in chronic granulomatous disease
-
Marciano BE, Rosenzweig SD, Kleiner DE, Anderson VL, Darnell DN, Anaya-O'Brien S, et al. Gastrointestinal involvement in chronic granulomatous disease. Pediatrics 2004; 114:462-468.
-
(2004)
Pediatrics
, vol.114
, pp. 462-468
-
-
Marciano, B.E.1
Rosenzweig, S.D.2
Kleiner, D.E.3
Anderson, V.L.4
Darnell, D.N.5
Anaya-O'Brien, S.6
-
4
-
-
0027397001
-
Outpatient management with oral corticosteroid therapy for obstructive conditions in chronic granulomatous disease
-
Danziger RN, Goren AT, Becker J, Greene JM, Douglas SD. Outpatient management with oral corticosteroid therapy for obstructive conditions in chronic granulomatous disease. J Pediatr 1993; 122:303-305.
-
(1993)
J Pediatr
, vol.122
, pp. 303-305
-
-
Danziger, R.N.1
Goren, A.T.2
Becker, J.3
Greene, J.M.4
Douglas, S.D.5
-
5
-
-
0025776247
-
Treatment of cutaneous sarcoidosis with chloroquine. Review of the literature
-
Zic JA, Horowitz DH, Arzubiaga C, King LE Jr. Treatment of cutaneous sarcoidosis with chloroquine. Review of the literature. Arch Dermatol 1991; 127:1034-1040.
-
(1991)
Arch Dermatol
, vol.127
, pp. 1034-1040
-
-
Zic, J.A.1
Horowitz, D.H.2
Arzubiaga, C.3
King Jr., L.E.4
-
6
-
-
0026637097
-
The urological manifestations of chronic granulomatous disease
-
Walther MM, Malech H, Berman A, Choyke P, Venzon DJ, Linehan WM, Gallin JI. The urological manifestations of chronic granulomatous disease. J Urol 1992; 147:1314-1318.
-
(1992)
J Urol
, vol.147
, pp. 1314-1318
-
-
Walther, M.M.1
Malech, H.2
Berman, A.3
Choyke, P.4
Venzon, D.J.5
Linehan, W.M.6
Gallin, J.I.7
-
7
-
-
0016799699
-
Gastric outlet obstruction due to X-linked chronic granulomatous disease
-
Johnson FE, Humbert JR, Kuzela DR, Todd JK, Lilly JR. Gastric outlet obstruction due to X-linked chronic granulomatous disease. Surgery 1975; 78:217-223.
-
(1975)
Surgery
, vol.78
, pp. 217-223
-
-
Johnson, F.E.1
Humbert, J.R.2
Kuzela, D.R.3
Todd, J.K.4
Lilly, J.R.5
-
8
-
-
0020385256
-
Chronic granulomatous disease of childhood presenting as gastric outlet obstruction
-
Varma VA, Sessions JT, Kahn LB, Lipper S. Chronic granulomatous disease of childhood presenting as gastric outlet obstruction. Am J Surg Pathol 1982; 6:673-676.
-
(1982)
Am J Surg Pathol
, vol.6
, pp. 673-676
-
-
Varma, V.A.1
Sessions, J.T.2
Kahn, L.B.3
Lipper, S.4
-
9
-
-
0028835569
-
Treatment of intractable gastrointestinal manifestations of chronic granulomatous disease with cyclosporine
-
Rosh JR, Tang HB, Mayer L, Groisman G, Abraham SK, Prince A. Treatment of intractable gastrointestinal manifestations of chronic granulomatous disease with cyclosporine. J Pediatr 1995; 126:143-145.
-
(1995)
J Pediatr
, vol.126
, pp. 143-145
-
-
Rosh, J.R.1
Tang, H.B.2
Mayer, L.3
Groisman, G.4
Abraham, S.K.5
Prince, A.6
-
10
-
-
0000391671
-
-
Ziegler HK, Unanue ER. Decrease in macrophage antigen catabolism caused by ammonia and chloroquine is associated with inhibition of antigen presentation to T cells. Proc Natl Acad Sci U S A 1982; 79:175-178.
-
Ziegler HK, Unanue ER. Decrease in macrophage antigen catabolism caused by ammonia and chloroquine is associated with inhibition of antigen presentation to T cells. Proc Natl Acad Sci U S A 1982; 79:175-178.
-
-
-
-
11
-
-
0020510235
-
Pharmacologial actions of 4-aminoquinoline compounds
-
Mackenzie AH. Pharmacologial actions of 4-aminoquinoline compounds. Am J Med 1983; 75:5-10.
-
(1983)
Am J Med
, vol.75
, pp. 5-10
-
-
Mackenzie, A.H.1
-
12
-
-
0009955883
-
Further studies on the mechanism of action of chloroquine: Inhibition of DNA and RNA polymerase reactions
-
Cohen SN, Yielding KL. Further studies on the mechanism of action of chloroquine: inhibition of DNA and RNA polymerase reactions. Arthritis Rheum 1964; 7:302-370.
-
(1964)
Arthritis Rheum
, vol.7
, pp. 302-370
-
-
Cohen, S.N.1
Yielding, K.L.2
-
13
-
-
0027155777
-
Selective regulation of cytokine secretion by hydroxychloroquine: Inhibition of interleukin 1 alpha (IL-1-alpha) and IL-6 in human monocytes and T cells
-
Sperber K, Quraishi H, Kalb TH, Panja A, Stecher V, Mayer L. Selective regulation of cytokine secretion by hydroxychloroquine: inhibition of interleukin 1 alpha (IL-1-alpha) and IL-6 in human monocytes and T cells. J Rheumatol 1993; 20:803-808.
-
(1993)
J Rheumatol
, vol.20
, pp. 803-808
-
-
Sperber, K.1
Quraishi, H.2
Kalb, T.H.3
Panja, A.4
Stecher, V.5
Mayer, L.6
-
14
-
-
0034254555
-
Chloroquine interferes with liposaccharide-induced TNF-α gene expression by a nonlysomotropic mechanism
-
Weber SM, Levitz SM. Chloroquine interferes with liposaccharide-induced TNF-α gene expression by a nonlysomotropic mechanism. J Immunol 2000; 165:1534-1540.
-
(2000)
J Immunol
, vol.165
, pp. 1534-1540
-
-
Weber, S.M.1
Levitz, S.M.2
-
15
-
-
0032535301
-
Host defense molecule polymorphisms influence the risk for immune-mediated complications in chronic granulomatous disease
-
Foster CB, Lehrnbecher T, Mol F, Steinberg SM, Venzon DJ, Walsh TJ, et al. Host defense molecule polymorphisms influence the risk for immune-mediated complications in chronic granulomatous disease. J Clin Invest 1998; 102:2146-2155.
-
(1998)
J Clin Invest
, vol.102
, pp. 2146-2155
-
-
Foster, C.B.1
Lehrnbecher, T.2
Mol, F.3
Steinberg, S.M.4
Venzon, D.J.5
Walsh, T.J.6
|